Log in to save to my catalogue

Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in th...

Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in th...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c1dc6fb9cc504fe096a25e7b0c381dfa

Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis

About this item

Full title

Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis

Publisher

United States: John Wiley & Sons, Inc

Journal title

Brain and behavior, 2021-12, Vol.11 (12), p.e2405-n/a

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Background
An association has been found between the presence of lipid‐specific oligoclonal IgM bands (LS‐OCMB) in cerebrospinal fluid and a more severe clinical multiple sclerosis course.
Objective
To investigate lipid‐specific oligoclonal IgM bands as a prognostic biomarker of cognitive impairment in the early stages of multiple sclerosi...

Alternative Titles

Full title

Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c1dc6fb9cc504fe096a25e7b0c381dfa

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c1dc6fb9cc504fe096a25e7b0c381dfa

Other Identifiers

ISSN

2162-3279

E-ISSN

2162-3279

DOI

10.1002/brb3.2405

How to access this item